Sarina Rogers is a member of our Transactions Practice Group and is based in our San Diego office.
Sarina began at Foley as a summer associate and gained valuable insights into complex legal matters, contributing to projects that required strong analytical skills and attention to detail. Prior to law school, Sarina worked as on onsite specialist at the UC San Diego Medical Center, providing clinical surgical support. In addition to her medical background, Sarina holds a BS in Biological Psychology. Her unique background allows her to tie together clinical and technical skills to best support her clients, especially in the Health Care & Life Sciences sector.
Since joining the firm, Sarina has built a versatile transactional practice representing both companies and investors across the full lifecycle of corporate growth — from seed-stage venture capital financings to late-stage rounds exceeding $200 million and strategic acquisitions. In the health care and life sciences sector, she regularly advises on high-value venture financings for clinical-stage biotechnology and therapeutics companies, as well as M&A transactions involving health technology platforms. Her technology, fintech, and AI practice is equally robust, encompassing acquisitions, Series A through Series C financings, strategic growth equity investments, and seed-stage deals on behalf of leading venture capital funds such as New Enterprise Associates (NEA), Cortical Ventures, and Cervin Ventures. Sarina’s deal experience spans a wide range of transaction sizes and structures, reflecting her ability to navigate the distinct regulatory, commercial, and strategic considerations that arise across each of these sectors.
Representative Experience
- Represented Gatik, the leader in autonomous trucking, in their $200 million Series D financing, as well as the company’s partnership with PepsiCo.
- Represented Rivet Health Inc., a leader in revenue cycle analytics, in its acquisition by leading health care technology solutions provider Zelis.
- Represented Unico, Brazil’s leading IDtech company, in the acquisition of OwnID, a U.S.-based startup specializing in passwordless and passkey authentication.
- Represented Ume, the fintech reshaping credit in Brazil, in their $21 million in Series B funding round led by Valor Capital Group and Bewater.
- Represented OpenLight, a world leader in custom Photonic Application-Specific Integrated Circuit (PASIC) chip design and manufacturing based on heterogenous integration, in their oversubscribed $34 million Series A financing.
- Represented Cortical Ventures as the lead investor in the Series Seed Preferred Stock financing of Spear AI, a leading developer of maritime artificial intelligence solutions.
- Represented HeroDevs, a provider of security and compliance solutions for deprecated open-source software, in securing a $125 million strategic growth investment from PSG, a growth equity firm focused on software and technology-enabled services companies. Existing investor Album also participated in the round.
- Represented Cervin Ventures as the lead investor in the $10 million seed funding round for Callidus Legal AI.
- Represented New Enterprise Associates (NEA) as the lead investor in the $26.5 million Series B funding round for Brazilian fintech startup NG.CASH.
- Represented New Enterprise Associates (NEA) as the lead investor in the $200 million Series C financing for Abcuro, a clinical-stage biotechnology company.
- Represented TCG Crossover (TCGX) and Omega Funds as lead investors in the $207.5 million Series C financing for Aviceda Therapeutics (Aviceda).
- Represented Wine Access, a leading online platform for discovering and purchasing premium wines and a Norwest Venture Partners portfolio company, in their acquisition by Full Glass Wine Co.